“Every Friday the same diabetic foot ulcer patient returns, oozing and unchanged, so I know Monday’s readmission order is coming.”
You’ve done everything right, but ulcers keep returning, advanced therapies are denied, reimbursements are razor thin, and claw backs hang over every patient file.
A 2024 meta-analysis of 15 randomized controlled trials (1,012 patients) found that autologous Platelet-Rich Plasma (PRP) more than doubled complete-healing odds (risk ratio 2.72, 95% CI: 1.95–3.79) and cut closure time by 18.7 days.1
Speeds up wound closure by an average of 19 days1
~$770 per treatment† under G0460/G0465 codes4
Accepted by more Medicare & Medicaid plans
Streamlined process. Minimal setup. No high-cost hurdles, just simple, regenerative care.
Optional LED activation boosts regenerative signaling up to 700%.6
Optional PRF matrix creates a uniform scaffold for complete wound coverage7
CLINICAL EVIDENCE
49% lower wound infection rate
(1,010 patients reviewed)8
55% fewer major amputations
(22 trials reviewed)9
Granulation 37% faster, infection rate 45% lower, 100% scaffold retention at 7 days8
71% healing rate with PRP and Negative Pressure Wound Therapy vs 36% without.
Closure time reduced by 21.2 days7
National non-facility supply payment set at $770.83 for G0460 and G04654
Class II medical device certification5
Efficient platelet concentration
Pyrogen-free processing
5-8mL yield per tube
Medicare Eligible: Qualifies for G0465 reimbursement when used for chronic diabetic wounds and G0460 with non-diabetic wounds or ulcers (with proper documentation and FDA-cleared device requirements.)4
European Study: Clinical research demonstrates significantly enhanced growth factor release withsustained activity over 28 days compared to traditional activation methods.6
Clinical Research: Studies show that thermal conversion creates a more stable fibrin matrix with enhanced mechanical properties and superior wound coverage capabilities.6
Medicare covers autologous PRP for chronic non-healing diabetic wounds under specific conditions
Important Coverage Limitations:
Coverage is determined by local Medicare Administrative Contractors (MACs) and may vary by region and case. Treatment beyond 20 weeks may require additional documentation.
Yes. Code G0465 for diabetic chronic ulcers and G0460 for non-diabetic chronic wounds and ulcers. National rate ≈ $770 per treatment†. Payment requires National Coverage Determination (NCD) 270.3 compliance and use of an FDA-cleared kit.
PRF Matrix forms a 3D scaffold, stays in tunneling wounds, and speeds granulation ~40%, leading to faster wound healing and less visits.
No. PRP injections outside chronic-wound care use CPT 0232T, which Medicare reimburses at $0.
Blood draw < 2 min, centrifuge 8 min, injection 4 min = ~14 minutes total. Optional LED activation and PRF Matrix each add 10 minutes → max 34 minutes.
Schedule a free consultation with our team and let’s make things happen!
